SEARCH

SEARCH BY CITATION

References

  • 1
    Valaperti A, Marty RR, Kania G et al. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J Immunol 2008; 180:26862695.
  • 2
    Bachmaier K, Neu N, de la Maza LM et al. Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999; 283:13351339.
  • 3
    Caforio AL, Mahon NJ, McKenna WJ. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity 2001; 34:199204.
  • 4
    Lv H, Havari E, Pinto S et al. Impaired thymic tolerance to alpha-myosin directs autoimmunity to the heart in mice and humans. J Clin Invest 2011; 121:15611573.
  • 5
    Kishimoto C, Kuribayashi K, Fukuma K et al. Immunologic identification of lymphocyte subsets in experimental murine myocarditis with encephalomyocarditis virus. Different kinetics of lymphocyte subsets between the heart and the peripheral blood, and significance of Thy 1.2+ (pan T) and Lyt 1+, 23+ (immature T) subsets in the development of myocarditis. Circ Res 1987; 61:715725.
  • 6
    Yajima T, Knowlton KU. Viral myocarditis: from the perspective of the virus. Circulation 2009; 119:26152624.
  • 7
    Vlasselaers D. Glucose-insulin-potassium: much more than enriched myocardial fuel. Circulation 2011; 123:129130.
  • 8
    Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 2010; 90:15071546.
  • 9
    Kovacs K, Hanto K, Bognar Z et al. Prevalent role of Akt and ERK activation in cardioprotective effect of Ca(2+) channel- and beta-adrenergic receptor blockers. Mol Cell Biochem 2009; 321:155164.
  • 10
    Turner NA. Therapeutic regulation of cardiac fibroblast function: targeting stress-activated protein kinase pathways. Future Cardiol 2011; 7:673691.
  • 11
    Marty RR, Dirnhofer S, Mauermann N et al. MyD88 signaling controls autoimmune myocarditis induction. Circulation 2006; 113:258265.
  • 12
    Eriksson U, Ricci R, Hunziker L et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 2003; 9:14841490.
  • 13
    Cihakova D, Rose NR. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv Immunol 2008; 99:95114.
  • 14
    Cariou A, Vinsonneau C, Dhainaut JF. Adjunctive therapies in sepsis: an evidence-based review. Crit Care Med 2004; 32:S562570.
  • 15
    Ellger B, Debaveye Y, Vanhorebeek I et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 2006; 55:10961105.
  • 16
    Vlasselaers D, Mesotten D, Langouche L et al. Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery. Ann Thorac Surg 2010; 90:2229.
  • 17
    Dandona P, Aljada A, Mohanty P et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 2001; 86:32573265.
  • 18
    Hansen TK, Thiel S, Wouters PJ et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 88:10821088.
  • 19
    Hartell NA, Archer HE, Bailey CJ. Insulin-stimulated endothelial nitric oxide release is calcium independent and mediated via protein kinase B. Biochem Pharmacol 2005; 69:781790.
  • 20
    Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 2004; 239:553560.
  • 21
    Sato Y, Kita T, Takatsu Y et al. Biochemical markers of myocyte injury in heart failure. Heart 2004; 90:11101113.
  • 22
    Ou L, Li W, Liu Y et al. Animal models of cardiac disease and stem cell therapy. Open Cardiovasc Med J 2010; 4:231239.
  • 23
    Sack MN, Yellon DM. Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation. J Am Coll Cardiol 2003; 41:14041407.
  • 24
    Miki T, Miura T, Tanno M et al. Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway. Basic Res Cardiol 2007; 102:163170.
  • 25
    Gao F, Gao E, Yue TL et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002; 105:14971502.